Medicamentos de actualidad = Drugs of today

• 

  Año 2015, Vol. 51, Número 8

  • MONOGRAPHS

    • Collagenase Clostridium histolyticum for the pharmacological management of Peyronie's disease.

      J. Anaissie, M.K Powers, Wayne J.G. Hellstrom, F.A. Yafi

      • Resumen

      págs. 457-468

      

    • Fluticasone furoate/vilanterol combination for the treatment of asthma and COPD.

      M Corsetti, C.J. Tack

      • Resumen

      págs. 469-478

      

    • Naloxegol: the first orally administered, peripherally acting, μ opioid receptor antagonist, approved for the treatment of opioid-induced constipation.

      M Corsetti, C.J. Tack

      • Resumen

      págs. 479-490

      

    • Panobinostat, a pan-histone deacetylase inhibitor: rationale for and application to treatment of multiple myeloma.

      T.O. Cheng, L Grasse, A.J. Shah, M. J. Chandra

      • Resumen

      págs. 491-504

      

  • REVIEW

    • Drug–device combination products: regulatory landscape and market growth.

      L. Bayarri

      • Resumen

      págs. 505-513